Insights

In-depth articles and expert analysis from pharmaceutical leaders, exploring advances in life sciences, drug development and the trends shaping healthcare innovation.

Pharmatica image of a glass globe illuminated from within by bright yellow light, surrounded by blue data lines, symbolising AI bringing light, intelligence, and innovation to global healthcare through the Anthropic and Gates Foundation Partnership.

Artificial Intelligence in Healthcare AI Pharma AI & Machine Learning

Anthropic’s Gates Foundation Partnership and Healthcare AI

Nicole Dale

Pharmatica image representing AI and machine learning in sterile pharmaceutical manufacturing. The image shows precision glass ampoules with a digital data mesh overlay, symbolising AI-driven quality and contamination detection.

Sterile Manufacturing Quality Continuous Manufacturing

Can AI and Machine Learning in Sterile Manufacturing Improve Quality?

Nicole Dale

Optimising clinical trial data collection Pharmatica image representing fit-for-purpose evidence generation.

Clinical Data Clinical Outcomes Clinical Trial Design

Optimising Clinical Trial Data Collection for Better Decisions

Nicole Dale

Pharmatica image showing a pharmaceutical R&D portfolio management meeting reviewing drug discovery pipeline progression, translational science, and pharmaceutical R&D success rates using evidence-based portfolio strategy.

What Drives Pharmaceutical R&D Success? New Benchmarking Reveals Why Some Drug Pipelines Outperform Others

Pharmatica image showing a clinical geneticist using LLM-assisted rare disease diagnosis tools to analyse genome sequencing data and generate evidence-based diagnostic hypotheses for precision medicine.

Can Large Language Models Solve More Rare Disease Genomes?

Pharmatica image showing modular pharmaceutical manufacturing using continuous pharmaceutical manufacturing processes, interconnected production modules, and Process Analytical Technology to improve flexible drug manufacturing.

Modular Pharma Factories: The Next Step for Continuous Manufacturing?

Explore All Insights

Browse our complete library of expert articles and analysis. Explore content across science, policy and life sciences innovation.

Nicole Dale

Genomic Governance Ensures Equity at the Core of Drug Discovery

Scientists analysing diverse genomic datasets to support genomic equity, AI-driven drug discovery, and precision medicine in pharmaceutical research.

Discover why genomic equity is essential for reliable AI-driven drug discovery, precision medicine, and building more representative pharmaceutical innovation.

Nicole Dale

FDA Registration for Drug Manufacturing Enters a New Era

Modern pharmaceutical manufacturing facility with stainless steel equipment, automated vial conveyor, and red digital data wave overlay symbolising FDA regulatory oversight and digital quality systems.

The FDA's proposed drug manufacturing modernisation rule could accelerate distributed manufacturing, digital quality systems, and pharma supply chain resilience.

Nicole Dale

AAV Vector Manufacturing: Solving Gene Therapy's Bottleneck

Scientist’s gloved hands handling a vial and pipette in a bright laboratory with a glowing DNA helix and AAV capsid, representing advanced AAV vector manufacturing and gene therapy process development.

Discover how innovations in AAV vector manufacturing are improving scalability, quality, and commercial readiness for next-generation gene therapies.

Nicole Dale

11 Clinical Trials Defining Pharmaceutical Strategy in 2026

The top 11 clinical trials 2026 highlighting breakthrough pharmaceutical innovations across obesity, gene editing, cardiovascular disease, psychiatry, and rare diseases.

We've mapped the competitive, regulatory, and commercial stakes of the top 11 clinical trials that have defined pharma strategy so far in 2026.

Nicole Dale

Anthropic’s Big AI Drug Discovery Announcement

Anthropic drug discovery programme combines AI research with pharmaceutical R&D as a scientist uses advanced analytics to accelerate neglected disease drug discovery.

Anthropic's new drug discovery programme marks a strategic shift from sole AI software provider to active R&D participant. Here's what it means for pharmaceutical innovation.

Nicole Dale

Digital Measures in Clinical Trials: FDA vs EMA Pathways

Clinician reviewing digital measures in clinical trials on a tablet, illustrating regulatory acceptance of digital health technologies, digital biomarkers, and FDA and EMA qualification pathways for modern clinical research.

Explore how novel digital measures gain regulatory acceptance in clinical trials, comparing FDA-structured pathways with EMA engagement-led frameworks.

Nicole Dale

FDA Draft Guidance on Gene Editing Safety (2026)

DNA double helix illustrating the FDA gene editing draft guidance 2026, highlighting next-generation sequencing (NGS) safety assessment, off-target editing analysis, genomic integrity testing, and regulatory requirements for cell and gene therapy development.

The FDA’s 2026 gene editing draft guidance could change your regulatory strategy. Explore the new NGS requirements for cell and gene editing therapies.

Nicole Dale

Next-Generation Sequencing for Cell Line Development in Biologics Manufacturing

Laboratory illustrating next-generation sequencing cell line development for biologics manufacturing, highlighting DNA analysis, genomic characterisation, bioprocess development, Quality by Design, and pharmaceutical manufacturing innovation.

Discover how next-generation sequencing in cell line development is improving biologics manufacturing, quality control, and regulatory confidence.

Nicole Dale

Real-Time Clinical Trials Are a Huge Competitive Advantage

Clinical researcher analysing live clinical trial dashboards and digital analytics, illustrating real-time clinical trials, continuous clinical trial data monitoring, adaptive trial management, and data-driven decision-making in pharmaceutical research.

Real-time clinical trials enable continuous data capture and faster decisions, improving how data is used in clinical trials. Here is what pharma leaders need to know.

Nicole Dale

Optimising Preclinical Pharmacology for Oncology NMEs

Oncology researcher performing preclinical pharmacology testing for new molecular entities (NMEs), illustrating oncology drug development, translational research, biomarker discovery, and advanced preclinical model optimisation.

Over 90% of oncology NMEs that succeed in animal studies fail in clinical trials. This analysis examines how to optimise preclinical pharmacology models to improve translational success.

Nicole Dale

Could Biological Age Become Pharma's Most Important Biomarker?

Biomarkers biological age illustration showing a human silhouette, DNA strands and AI-powered health analysis representing precision medicine and longevity research.

New research shows biomarkers of biological age predict mortality and hospitalisation better than chronological age, opening new opportunities for pharma innovation.

Nicole Dale

FDA 2026 Draft Guidance on Alternatives to Animal Testing

Illustration representing FDA alternatives to animal testing, featuring laboratory research, organ-on-chip technology, genetic science, AI-enabled drug discovery and next-generation pharmaceutical testing methods.

The FDA's March 2026 draft guidance on alternatives to animal testing marks a pivotal shift in preclinical drug development. Here's what pharma R&D teams need to know.

Topic